Patent: 8,859,572
✉ Email this page to a colleague
Summary for Patent: 8,859,572
| Title: | Sulfone substituted 2,3-dihydroimidazo [1,2-C] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis |
| Abstract: | This invention relates to novel sulfone 2I3-dihydroimidazo[1 l2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis mediated disorders, as a sole agent or in combination with other active ingredients. |
| Inventor(s): | Hentemann; Martin F. (Carlisle, MA), Scott; William (Guilford, CT), Wood; Jill (Ft. Collins, CO), Johnson; Jeffrey (North Branford, CT), Redman; Aniko (Durham, NC), Bullion; Ann-Marie (King of Prussia, PA), Guernon; Leatte (Moodus, CT) |
| Assignee: | Bayer Intellectual Property GmbH (Monheim, DE) |
| Application Number: | 12/812,911 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,859,572
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Teknika Llc | TICE BCG | bcg live | For Injection | 102821 | 06/21/1989 | ⤷ Try a Trial | 2039-02-26 |
| Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2039-02-26 |
| Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2039-02-26 | |
| Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2039-02-26 | |
| Baxalta Us Inc. | GAMMAGARD, GAMMAGARD S/D, IVEEGAM | immune globulin intravenous (human) | For Injection | 103133 | 02/18/1986 | ⤷ Try a Trial | 2039-02-26 |
| Baxalta Us Inc. | GAMMAGARD, GAMMAGARD S/D, IVEEGAM | immune globulin intravenous (human) | For Injection | 103133 | 07/27/2000 | ⤷ Try a Trial | 2039-02-26 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
